Mycophenolate mofetil - Suggested guidelines for use in kidney transplantation

被引:19
|
作者
Behrend, M [1 ]
机构
[1] Hannover Med Sch, Abt Viszeral & Transplantat Chirurg, D-30623 Hannover, Germany
关键词
D O I
10.2165/00063030-200115010-00004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mycophenolate mofetil (MMF) is an immunosuppressive drug designed to inhibit inosine monophosphate dehydrogenase (IMPDH). IMPDH is a key enzyme in the de novo purine synthesis of lymphocytes, It is crucially important for proliferative responses of human T and B lymphocytes, The inhibition of IMPDH thus leads to selective lymphocyte suppression. After successful use in various in vitro and animal models, MMF was brought to clinical trial in patients undergoing transplantation. The drug is rapidly and completely absorbed following oral administration. Pilot studies of administration with cyclosporin and corticosteroids suggested a significant reduction in the incidence of organ rejection at dosages of 1 to 3 g/day, As a result of these studies, 3 pivotal randomised double-blind multicentre trials, involving nearly 1500 patients, were designed to investigate the effects of addition of MMF to different standard immunosuppressive protocols on the prevention of acute renal allograft rejection. After 6 months, the rates of biopsy-proven rejection were significantly reduced in patients receiving MMF. In combination with cyclosporin and corticosteroids, the adverse effect profile resembled that of azathioprine. Most adverse effects were associated with the gastrointestinal tract, the blood system and opportunistic infections. MMF offers improved immunosuppressive therapy following renal and probably other solid organ transplantation. MMF has born licensed since 1995 for the prevention of acute renal allograft rejection in most countries. It has been used in different combinations of immunosuppressive drugs and in various dosages and regimens.
引用
收藏
页码:37 / 53
页数:17
相关论文
共 50 条
  • [41] Dietary Intake and Mycophenolate Mofetil-related Diarrhea Following Kidney Transplantation
    Onyeaghala, G.
    Teigen, L.
    Guo, B.
    Doronin, Y.
    Al-Kofahi, M.
    Wu, B.
    Guan, W.
    Staley, C.
    Riad, S.
    Matas, A.
    Remmel, R.
    Oetting, W.
    Dorr, C.
    Jacobson, P.
    Israni, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 577 - 577
  • [42] CONGENITAL MALFORMATIONS WITH LOW-DOSE MYCOPHENOLATE MOFETIL AFTER KIDNEY TRANSPLANTATION
    Koshy, Anoop N.
    Strong, David
    Earles, Gavin
    Fassett, Robert G.
    NEPHROLOGY, 2010, 15 (01) : 134 - 135
  • [43] Acute inflammatory syndrome induced by mycophenolate mofetil in a patient following kidney transplantation
    Hochegger, K
    Gruber, J
    Lhotta, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) : 852 - 854
  • [44] Mycophenolate Mofetil and Tacrolimus Reduce Mortality After Deceased Donor Kidney Transplantation
    Gonzalez-Molina, M.
    Ruiz-Esteban, P.
    Burgos, D.
    Rodriguez, M. A.
    Cabello, M.
    Gutierrez, E.
    Hernandez, D.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2577 - 2578
  • [45] Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab
    Baek, Chung Hee
    Kim, Hyosang
    Yu, Hoon
    Shin, Eunhye
    Cho, Hyungjin
    Yang, Won Seok
    Han, Duck Jong
    Park, Su-Kil
    BMC NEPHROLOGY, 2015, 16
  • [46] Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation
    Srinivas, T. R.
    Schold, J. D.
    Guerra, G.
    Eagan, A.
    Bucci, C. M.
    Meier-Kriesche, H. -U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (03) : 586 - 594
  • [47] Mycophenolate mofetil monotherapy in liver transplantation
    Pierini, A
    Mirabella, S
    Brunati, A
    Ricchiuti, A
    Franchello, A
    Salizzoni, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) : 2614 - 2615
  • [48] Mycophenolate mofetil, HCV and liver transplantation
    Macedo, G
    Maia, JC
    Gomes, A
    Ferreira, A
    Campos, M
    Araujo, F
    Carneiro, F
    JOURNAL OF HEPATOLOGY, 2002, 36 : 190 - 190
  • [49] Mycophenolate mofetil in cadaveric renal transplantation
    Cho, S
    Danovitch, G
    Deierhoi, M
    Ferguson, R
    Gonwa, T
    Hodge, E
    Johnson, C
    Miller, J
    Neylan, JL
    Norman, D
    Pescovitz, MD
    Sollinger, HW
    Tomlanovich, SJ
    Weinstein, S
    Wang, W
    Rees, MM
    Ramos, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (02) : 296 - 303
  • [50] Mycophenolate mofetil - Effects on clinical transplantation
    Holt, CD
    Sievers, TM
    Ghobrial, RM
    Rossi, SJ
    Goss, JA
    McDiarmid, SV
    BIODRUGS, 1998, 10 (05) : 373 - 384